Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.
Today, our focus is on Novamind (NM.C), a company attempting to capitalize on the psychedelics market boom. Is it real value or a hallucinogenic nightmare?
Enjoy!
The post Novamind (NM.C) – Investor Roundtable appeared first on Equity.Guru.
